| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/21/2012 | US8119359 Methods of indentifying sweet taste modulators |
| 02/21/2012 | US8119358 Diabetes-related biomarkers and methods of use thereof |
| 02/21/2012 | US8119357 Method for analyzing a glycomolecule |
| 02/21/2012 | US8119356 Identification method of glycoproteins using a specific lectin precipitation |
| 02/21/2012 | US8119355 Biomarkers for cancer sensitivity and uses thereof |
| 02/21/2012 | US8119354 Cell-free assay product and method of use thereof for measuring activity of frizzled receptors |
| 02/21/2012 | US8119350 Method of surface plasmon resonance (SPR) to detect genomic aberrations in patients with multiple myeloma |
| 02/21/2012 | US8119340 Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia |
| 02/21/2012 | US8119339 Heteroduplex tracking assay |
| 02/21/2012 | US8119171 Method for the prevention or reduction of haze in beverages |
| 02/21/2012 | US8119138 Anti-estrogen and immune modulator combinations for treating breast cancer |
| 02/21/2012 | US8119069 Test element analysis system |
| 02/21/2012 | US8119068 Fluid content monitor |
| 02/21/2012 | US8118993 Small volume in vitro analyte sensor and methods of making |
| 02/21/2012 | US8118992 Small volume in vitro analyte sensor |
| 02/21/2012 | US8117734 Method of making an electrochemical sensor |
| 02/21/2012 | CA2693055C Systems and methods for enhancing fluorescent detection of target molecules in a test sample |
| 02/21/2012 | CA2589996C Transmission spectroscopy system for use in the determination of analytes in body fluid |
| 02/21/2012 | CA2544470C Microwell array chip and method of manufacturing same |
| 02/21/2012 | CA2534585C Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 02/21/2012 | CA2504307C Manufacture of electrochemical sensors by moveable flat screen printing |
| 02/21/2012 | CA2473244C High-density lipoprotein assay device and method |
| 02/21/2012 | CA2434657C Determining the pvt properties of a hydrocarbon reservoir fluid |
| 02/21/2012 | CA2418962C Anti-dual integrin antibodies, compositions, methods and uses |
| 02/21/2012 | CA2398940C Methods and compositions using stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 02/21/2012 | CA2386506C Isolation of precursor cells and their use for tissue repair |
| 02/21/2012 | CA2350185C Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 02/21/2012 | CA2322055C Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 02/21/2012 | CA2264592C Bioconjugates and delivery of bioactive agents |
| 02/21/2012 | CA2263835C Stimulus-inducible i (kappa)b kinase [ikk] signalsome |
| 02/17/2012 | CA2750329A1 Downregulation of spy1 by p53 as an essential component of p53-mediated effects |
| 02/17/2012 | CA2749473A1 Standoff explosives detector using deep-uv raman spectroscopy |
| 02/16/2012 | WO2012021907A2 Vincristine immunoassay |
| 02/16/2012 | WO2012021887A2 Biomarkers for the early detection of breast cancer |
| 02/16/2012 | WO2012021785A1 Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (hppd) activity |
| 02/16/2012 | WO2012021741A2 Lateral flow assays for non-diagnostic analytes |
| 02/16/2012 | WO2012021733A2 Photodamage mitigation compounds and systems |
| 02/16/2012 | WO2012021714A2 Biomarker signatures for wellness testing |
| 02/16/2012 | WO2012021707A2 Premature-termination-codons readthrough compounds |
| 02/16/2012 | WO2012021648A1 Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies |
| 02/16/2012 | WO2012021469A1 ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF |
| 02/16/2012 | WO2012021458A1 Isotonic buffered composition and method that enables counting of cells |
| 02/16/2012 | WO2012021453A2 Evaluating anti-inflammatory responses |
| 02/16/2012 | WO2012021407A2 Biomarkers for stroke |
| 02/16/2012 | WO2012021390A1 Ligands and methods for labeling biomolecules in vivo |
| 02/16/2012 | WO2012021239A2 In vitro point-of-care sensor and method of use |
| 02/16/2012 | WO2012021178A1 Integrated diagnosis of heparin-induced thrombocytopenia |
| 02/16/2012 | WO2012021096A1 Method for fuel injection |
| 02/16/2012 | WO2012021045A2 Sentinel lymph node marker capable of multi-mode imaging |
| 02/16/2012 | WO2012021042A2 Method for crystallizing low mass ions for diagnosing colorectal cancer and method for diagnosing colorectal cancer using same |
| 02/16/2012 | WO2012020985A2 Method for analyzing aspirin in plasma with liquid chromatography-mass spectrometry |
| 02/16/2012 | WO2012020897A1 Model mouse of attention deficit hyperactivity disorder, method for investigating effects for preventing and alleviating attention disorder using the model mouse, and method for treating attention disorder by suppressing t-type calcium channel |
| 02/16/2012 | WO2012020869A1 Medicine box and method for managing mecidine |
| 02/16/2012 | WO2012020854A1 Method for measuring concentration of bioethanol in alcohol culture medium |
| 02/16/2012 | WO2012020839A1 Pharmaceutical composition for cancer therapy |
| 02/16/2012 | WO2012020745A1 Method for measuring glycosylated hemoglobin |
| 02/16/2012 | WO2012020711A1 Microchamber array device which has electrical function and inspection object analysis method using same |
| 02/16/2012 | WO2012020433A1 Portable device for monitoring and reporting of medical information for the evidence -based management of patients with chronic respiratory disease |
| 02/16/2012 | WO2012020385A1 Method for diagnosing neurodegenerative diseases |
| 02/16/2012 | WO2012020281A1 New markers for the epithelial and proliferative or mesenchymal invasive phenotype of human neoplasias |
| 02/16/2012 | WO2012020196A1 Method for quantifying the potentializing effect of fibrogen on the generation of thrombin and applications thereof |
| 02/16/2012 | WO2012020178A1 Method and device for measuring infrared absorption and breath alcohol tester comprising such a device |
| 02/16/2012 | WO2012020122A1 Process for avoiding false positive results in a detecting process of an inflammation indicator in a rinse solution for taking up gingival crevicular fluid |
| 02/16/2012 | WO2012020046A1 Method for the diagnosis of dry eye and blepharitis |
| 02/16/2012 | WO2012020045A1 Method for selecting patients with stable coronary artery disease for pci or medical treatment |
| 02/16/2012 | WO2012020038A1 Anti-tenascin-c a2 antibodies and methods of use |
| 02/16/2012 | WO2012020011A1 Devices and methods for controlling actin filaments growth and organization using micropatterned nucleation sites |
| 02/16/2012 | WO2012019957A1 Biomarkers for predicting maintenance of weight loss |
| 02/16/2012 | WO2012019828A1 Apparatus and method for separating constituent parts of a sample liquid |
| 02/16/2012 | WO2012019437A1 Bladder cancer tumor marker, antibiotic and application thereof |
| 02/16/2012 | WO2012019341A1 Method for extracting hexavalent chromium from plastic |
| 02/16/2012 | WO2012019300A1 Endometrial cancer biomarkers and methods of identifying and using same |
| 02/16/2012 | WO2012019214A1 Urine sampling |
| 02/16/2012 | WO2012019212A1 Kit comprising a testing device for determining the week of pregnancy |
| 02/16/2012 | WO2011163320A9 Method and apparatus for detecting and regulating vascular endothelial growth factor (vegf) by forming a homeostatic loop employing a half-antibody biosensor |
| 02/16/2012 | WO2011154260A3 Detection of drug exposure based on sebum composition |
| 02/16/2012 | WO2011149942A3 Compositions and methods for plasma peptide analysis |
| 02/16/2012 | WO2011141824A9 Methods for identifying nmda receptor modulators |
| 02/16/2012 | WO2011141766A8 Ferritin biosensor and methods of using the same |
| 02/16/2012 | WO2011141530A3 A luminescence based sensor |
| 02/16/2012 | WO2011133450A3 Serology assays |
| 02/16/2012 | WO2011133383A3 Methods and apparatus for determination of halohydrocarbons |
| 02/16/2012 | WO2011126740A9 Hip1 cancer markers |
| 02/16/2012 | WO2011112906A3 Novel immunogens and methods for discovery and screening thereof |
| 02/16/2012 | WO2011004148A8 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis |
| 02/16/2012 | US20120042416 Antibody fusion-mediated plant resistance against Oomycota |
| 02/16/2012 | US20120042413 Compositions And Methods Comprising Sequences Having Hydroxyphenylpyruvate Dioxygenase (HPPD) Activity |
| 02/16/2012 | US20120042407 Corn event 5307 |
| 02/16/2012 | US20120042400 Rtd receptor |
| 02/16/2012 | US20120042399 Immunogenic peptides |
| 02/16/2012 | US20120041915 Method for diagnosing urticaria and angioedema |
| 02/16/2012 | US20120041687 Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles |
| 02/16/2012 | US20120041341 Control solution packets and methods for calibrating bodily fluid sampling devices |
| 02/16/2012 | US20120041303 Phage antibodies to radiation-inducible neoantigens |
| 02/16/2012 | US20120041176 Ucp4 |
| 02/16/2012 | US20120041067 Methods of Inducing Terminal Differentiation |
| 02/16/2012 | US20120041048 COMPOSITIONS AND METHODS RELATING TO miR-31 |
| 02/16/2012 | US20120041017 Pyridocarbazole type compounds and applications thereof |
| 02/16/2012 | US20120040976 Small molecule immunomodulators for alzheimer's disease |
| 02/16/2012 | US20120040938 Glucocorticoid receptor alleles and uses thereof |